Tacrolimus and Pulmonary tuberculosis aggravated - a phase IV clinical study of FDA data
Summary:
We study 105,108 people who have side effects when taking Tacrolimus. Pulmonary tuberculosis aggravated is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Prednisone and have Immunodeficiency disorders.
The phase IV clinical study analyzes which people take Tacrolimus and have Pulmonary tuberculosis aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
105,108 people reported to have side effects when taking Tacrolimus.
Among them, 130 people (0.12%) have Pulmonary tuberculosis aggravated.
What is Tacrolimus?
Tacrolimus has active ingredients of tacrolimus. It is used in kidney transplant. Currently, eHealthMe is studying from 105,429 Tacrolimus users.
What is Pulmonary tuberculosis aggravated?
Pulmonary tuberculosis aggravated (serious lungs tuberculosis) is found to be associated with 574 drugs and 192 conditions by eHealthMe. Currently, we are studying 10 people who have Pulmonary tuberculosis aggravated.
Number of Tacrolimus and Pulmonary tuberculosis aggravated reports submitted per year:
Time on Tacrolimus when people have Pulmonary tuberculosis aggravated *:
Gender of people who have Pulmonary tuberculosis aggravated when taking Tacrolimus*:
Age of people who have Pulmonary tuberculosis aggravated when taking Tacrolimus *:
Common drugs people take besides Tacrolimus *:
Common side effects people have besides Pulmonary tuberculosis aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tacrolimus and have Pulmonary tuberculosis aggravated?
Check whether Pulmonary tuberculosis aggravated is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Tacrolimus side effects by duration, gender and age:
- Tacrolimus side effects (105,429 reports)
Pulmonary tuberculosis aggravated treatments and more:
- Pulmonary tuberculosis aggravated (10 reports)
Common drugs associated with Pulmonary tuberculosis aggravated:
- Remicade: 1,232 reports
- Methotrexate: 943 reports
- Prednisolone: 574 reports
- Prednisone: 414 reports
- Humira: 364 reports
- Isoniazid: 355 reports
- Enbrel: 238 reports
- Folic acid: 205 reports
- Mycophenolate mofetil: 170 reports
- Tacrolimus: 130 reports
All the drugs that are associated with Pulmonary tuberculosis aggravated:
- Pulmonary tuberculosis aggravated (574 drugs)
Common conditions associated with Pulmonary tuberculosis aggravated:
- Rheumatoid arthritis: 1,289 reports
- Crohn's disease: 464 reports
- Hiv infection: 365 reports
- Ankylosing spondylitis: 302 reports
- Psoriasis: 170 reports
- High blood pressure: 162 reports
All the conditions that are associated with Pulmonary tuberculosis aggravated:
- Pulmonary tuberculosis aggravated (192 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lidocaine Viscous and Sodium Bicarbonate drug interaction - 2 seconds ago
- Buscopan and Colon Cancer - 23 seconds ago
- Solu-Medrol and Eye Injury - 25 seconds ago
- Sulfatrim and Stools - Watery - 26 seconds ago
- Sulfatrim and Diarrhea - 26 seconds ago
- Fetzima and Drug Ineffective - 36 seconds ago
- Labetalol Hydrochloride and Synthroid drug interaction - 41 seconds ago
- Magnesium and Coreg Cr drug interaction - 57 seconds ago
- Kenalog-40 and Klor-Con drug interaction - 59 seconds ago
- Cenestin and Remicade drug interaction - 59 seconds ago